These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
655 related articles for article (PubMed ID: 32127478)
1. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Na TY; Schecterson L; Mendonsa AM; Gumbiner BM Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5931-5937. PubMed ID: 32127478 [TBL] [Abstract][Full Text] [Related]
2. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model. Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969 [TBL] [Abstract][Full Text] [Related]
3. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin. Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639 [TBL] [Abstract][Full Text] [Related]
4. The highly metastatic 4T1 breast carcinoma model possesses features of a hybrid epithelial/mesenchymal phenotype. Herndon ME; Ayers M; Gibson-Corley KN; Wendt MK; Wallrath LL; Henry MD; Stipp CS Dis Model Mech; 2024 Sep; 17(9):. PubMed ID: 39104192 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic Heterogeneity and Metastasis of Breast Cancer Cells. Hapach LA; Carey SP; Schwager SC; Taufalele PV; Wang W; Mosier JA; Ortiz-Otero N; McArdle TJ; Goldblatt ZE; Lampi MC; Bordeleau F; Marshall JR; Richardson IM; Li J; King MR; Reinhart-King CA Cancer Res; 2021 Jul; 81(13):3649-3663. PubMed ID: 33975882 [TBL] [Abstract][Full Text] [Related]
6. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. Hazan RB; Phillips GR; Qiao RF; Norton L; Aaronson SA J Cell Biol; 2000 Feb; 148(4):779-90. PubMed ID: 10684258 [TBL] [Abstract][Full Text] [Related]
7. Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patients. Bock C; Rack B; Huober J; Andergassen U; Jeschke U; Doisneau-Sixou S Future Oncol; 2014 Aug; 10(10):1751-65. PubMed ID: 25303055 [TBL] [Abstract][Full Text] [Related]
9. Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype. Hamilton G; Hochmair M; Rath B; Klameth L; Zeillinger R Cell Adh Migr; 2016 Jul; 10(4):360-7. PubMed ID: 26919626 [TBL] [Abstract][Full Text] [Related]
10. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo. Ziegler E; Hansen MT; Haase M; Emons G; Gründker C Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421 [TBL] [Abstract][Full Text] [Related]
11. E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells. Palen K; Weber J; Dwinell MB; Johnson BD; Ramchandran R; Gershan JA Oncotarget; 2016 Jul; 7(28):43363-43375. PubMed ID: 27270319 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
13. A Ca Dang DK; Makena MR; Llongueras JP; Prasad H; Ko M; Bandral M; Rao R Mol Cancer Res; 2019 Aug; 17(8):1735-1747. PubMed ID: 31076498 [TBL] [Abstract][Full Text] [Related]
14. The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen. Zheng X; Chen Y; Bai M; Liu Y; Xu B; Sun R; Zeng H Free Radic Biol Med; 2019 Feb; 131():7-17. PubMed ID: 30496814 [TBL] [Abstract][Full Text] [Related]
15. Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling. Zhang H; Meng F; Wu S; Kreike B; Sethi S; Chen W; Miller FR; Wu G Cancer Res; 2011 Jul; 71(14):4846-56. PubMed ID: 21750175 [TBL] [Abstract][Full Text] [Related]
16. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers. Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145 [TBL] [Abstract][Full Text] [Related]
17. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition. Arima Y; Inoue Y; Shibata T; Hayashi H; Nagano O; Saya H; Taya Y Cancer Res; 2008 Jul; 68(13):5104-12. PubMed ID: 18593909 [TBL] [Abstract][Full Text] [Related]
18. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells. Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057 [TBL] [Abstract][Full Text] [Related]
19. 1α,25-Dihydroxyvitamin D Inhibits the Metastatic Capability of MCF10CA1a and MDA-MB-231 Cells in an In Vitro Model of Breast to Bone Metastasis. Wilmanski T; Barnard A; Parikh MR; Kirshner J; Buhman K; Burgess J; Teegarden D Nutr Cancer; 2016 Oct; 68(7):1202-9. PubMed ID: 27552186 [TBL] [Abstract][Full Text] [Related]
20. Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells. Huaman J; Naidoo M; Zang X; Ogunwobi OO Cells; 2019 Jun; 8(6):. PubMed ID: 31226820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]